Southernsun Asset Management LLC Cuts Stake in U.S. Physical Therapy, Inc. $USPH

Southernsun Asset Management LLC decreased its position in U.S. Physical Therapy, Inc. (NYSE:USPH) by 8.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 439,904 shares of the company’s stock after selling 39,632 shares during the quarter. U.S. Physical Therapy makes up 4.8% of Southernsun Asset Management LLC’s investment portfolio, making the stock its 7th largest position. Southernsun Asset Management LLC’s holdings in U.S. Physical Therapy were worth $32,975,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Hantz Financial Services Inc. boosted its holdings in shares of U.S. Physical Therapy by 56.4% during the fourth quarter. Hantz Financial Services Inc. now owns 366 shares of the company’s stock worth $29,000 after purchasing an additional 132 shares during the period. Huntington National Bank increased its holdings in U.S. Physical Therapy by 15.4% during the 4th quarter. Huntington National Bank now owns 1,052 shares of the company’s stock valued at $82,000 after purchasing an additional 140 shares during the period. Osaic Holdings Inc. increased its holdings in U.S. Physical Therapy by 1.6% during the 2nd quarter. Osaic Holdings Inc. now owns 10,447 shares of the company’s stock valued at $817,000 after purchasing an additional 166 shares during the period. Snowden Capital Advisors LLC raised its position in U.S. Physical Therapy by 3.6% during the 2nd quarter. Snowden Capital Advisors LLC now owns 5,600 shares of the company’s stock valued at $438,000 after purchasing an additional 195 shares during the last quarter. Finally, Janney Montgomery Scott LLC raised its position in U.S. Physical Therapy by 6.7% during the 1st quarter. Janney Montgomery Scott LLC now owns 3,381 shares of the company’s stock valued at $253,000 after purchasing an additional 212 shares during the last quarter.

U.S. Physical Therapy Price Performance

Shares of NYSE USPH opened at $74.29 on Wednesday. U.S. Physical Therapy, Inc. has a 1 year low of $58.19 and a 1 year high of $93.50. The stock has a market capitalization of $1.13 billion, a P/E ratio of 148.58, a P/E/G ratio of 2.06 and a beta of 1.15. The company’s 50-day moving average is $66.47 and its 200 day moving average is $74.70. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.19 and a quick ratio of 1.19.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.46 EPS for the quarter, missing the consensus estimate of $0.55 by ($0.09). The company had revenue of $198.29 million during the quarter, compared to analysts’ expectations of $200.94 million. U.S. Physical Therapy had a return on equity of 8.81% and a net margin of 4.36%.The business’s quarterly revenue was up 7.9% on a year-over-year basis. During the same quarter last year, the business earned $0.48 earnings per share. On average, sell-side analysts expect that U.S. Physical Therapy, Inc. will post 2.99 earnings per share for the current year.

U.S. Physical Therapy Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, June 12th. Stockholders of record on Friday, May 22nd were given a $0.46 dividend. The ex-dividend date of this dividend was Friday, May 22nd. This represents a $1.84 annualized dividend and a dividend yield of 2.5%. U.S. Physical Therapy’s dividend payout ratio is currently 368.00%.

Analysts Set New Price Targets

Several equities research analysts have weighed in on USPH shares. Citigroup reiterated a “market outperform” rating on shares of U.S. Physical Therapy in a report on Wednesday, June 24th. Weiss Ratings restated a “hold (c-)” rating on shares of U.S. Physical Therapy in a report on Friday, May 29th. Zacks Research raised U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a research note on Wednesday, May 27th. Barrington Research dropped their price target on U.S. Physical Therapy from $103.00 to $90.00 and set an “outperform” rating for the company in a research note on Wednesday, May 13th. Finally, Citizens Jmp reiterated a “market outperform” rating and issued a $98.00 price target on shares of U.S. Physical Therapy in a report on Wednesday, June 24th. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, U.S. Physical Therapy has an average rating of “Moderate Buy” and an average price target of $97.50.

Insider Activity at U.S. Physical Therapy

In other news, Director Peter Francis Minan bought 492 shares of the stock in a transaction dated Monday, June 8th. The stock was bought at an average price of $63.14 per share, for a total transaction of $31,064.88. Following the purchase, the director directly owned 2,923 shares in the company, valued at $184,558.22. This trade represents a 20.24% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.40% of the stock is currently owned by insiders.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.